ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Clinical trial NCT05198154 · RECRUITING
Trial details
- NCT number
- NCT05198154
- Sponsor
- Fang Wu
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-24
- Primary completion
- 2025-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.